Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
35
Number of overlapping holdings
25.7%
% of XBI's 136 holdings also in WDNA
39.8%
% of WDNA's 91 holdings also in XBI
Overlap by Weight
Sector Drift (XBI minus WDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XBI |
Weight in WDNA |
Overlap | |
|---|---|---|---|---|
 |
NATERA INC | 3.5% | 2.2% | 2.2% |
|
BLUEPRINT MEDICINES CORP. | 1.7% | 2.6% | 1.7% |
|
SAREPTA THERAPEUTICS INC | 2.7% | 1.7% | 1.7% |
|
VERTEX PHARMACEUTICALS INC | 2.6% | 1.6% | 1.6% |
|
UNITED THERAPEUTICS CORP | 2.9% | 1.5% | 1.5% |
Position Highlights (Non-Overlapping Exposures)
XBI Overweight Relative to WDNA
|
INCYTE CORP | 2.9% |
|
ADVENTRX PHARMACEUTICALS INC | 2.8% |
|
NEUROCRINE BIOSCIENCES INC | 2.8% |
|
INSMED INC | 2.6% |
|
ABBVIE INC | 2.4% |
|
MADRIGAL PHARMACEUTICALS, INC. | 2.2% |
|
GILEAD SCIENCES INC | 1.9% |
|
VIKING THERAPEUTICS, INC. | 1.9% |
|
TG THERAPEUTICS INC | 1.7% |
|
EXACT SCIENCES CORP | 1.7% |
XBI Underweight Relative to WDNA
|
TWIST BIOSCIENCE CORP. | -3.3% |
 |
NOVOZYMES A/S-B SHARES | -2.7% |
|
FATE THERAPEUTICS INC | -2.1% |
|
ELI LILLY & CO | -2.1% |
|
AGIOS PHARMACEUTICALS INC | -1.8% |
|
VERICEL CORPORATION | -1.6% |
|
GERON CORP | -1.6% |
|
DANAHER CORP | -1.4% |
|
CATALENT INC | -1.3% |
 |
NOVARTIS AG | -1.3% |